BioSpace News Archive

SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the United Kingdom has approved SIGA’s oral tecovirimat (known in the U.S. as oral TPOXX) for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox in adults and children with a body weight of at least 13kg.

Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that following the live investor webinar presented by Dr Vladislav Sandler, Chief Executive Officer and Co-Founder of Hemogenyx Pharmaceuticals held on 6 July 2022, a recording of the webinar is now available to view on the Company’s YouTube channel at https://youtu.be/LFH95Zw8e6Y

Alimera Sciences, Inc. announces that Alimera Sciences Europe Limited, its Ireland-based European subsidiary, has received approval.

AbbVie (NYSE: ABBV) will announce its second-quarter 2022 financial results on Friday, July 29, 2022, before the market opens.

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced the granting of inducement awards to 18 new employees.

Jnana Therapeutics Data will be presented at the 2022 National PKU Alliance Conference in Vancouver, Wash. July 9 from 3-4:30 pm, as a poster titled “Inhibition of SLC6A19 as a Therapeutic Strategy for the Treatment of PKU.”

today announced that the Company’s recombinant adeno-associated virus (rAAV) vector-based investigational gene therapy for Canavan disease (CD) has shown encouraging early efficacy data and a favorable safety profile in the first three patients treated through their six month visit post-treatment in the Company’s open-label Phase 1/2 First-in-Human (FIH) clinical trial at Dayton Children’s Hospital (Dayton, Ohio).

New smart sensors, which assist in the soft tissue balancing and correct positioning of an orthopaedic implant during hip replacement, are expected to prolong implant lifetimes and reduce the chances of patients needing difficult revision surgery.

Forecast to 2027,’ thoroughly examines the Insomnia Therapy industry to provide essential data & information for the targeted readers.

First Automated Benchtop Fire Monkey HMW-DNA Extraction Installed at Quadram Institute for Pathogen Sequencing and AMR Monitoring.